Cannabinoids—A New Perspective in Adjuvant Therapy for Pulmonary Hypertension
Abstract Currently, no treatment can completely cure pulmonary hypertension (PH), which can lead to right ventricular failure and, consequently, death.…
vasorelaxation
Vasodilatory effects of cannabidiol in human pulmonary and rat small mesenteric arteries: modification by hypertension and the potential pharmacological opportunities
Abstract Objective: Cannabidiol (CBD) has been suggested as a potential antihypertensive drug. The aim of our study was to investigate…
In Vivo Cannabidiol Treatment Improves Endothelium-Dependent Vasorelaxation in Mesenteric Arteries of Zucker Diabetic Fatty Rats
Abstract Background and purpose: We have shown that in vitro treatment with cannabidiol (CBD, 2 h) enhances endothelial function in…
Cannabidiol causes endothelium-dependent vasorelaxation of human mesenteric arteries via CB1 activation
Abstract Aims: The protective effects of cannabidiol (CBD) have been widely shown in preclinical models and have translated into medicines…